Peter D. Katsikis
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia.
Journal: Frontiers in immunology
Published: February 03, 2026
HIV-1 reservoir inducibility and immune phenotypes after prolonged analytical treatment interruption: a long-term follow-up study.
Journal: EBioMedicine
Published: January 26, 2026
A Multifaceted Interplay Among Hemophagocytosis, Interleukin-18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 30, 2025
Distinct natural killer cell signature in still's disease: Insights from a multinational immunome project consortium for autoinflammatory disorders.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 29, 2025
Distinct Natural Killer Cell Signature in Still Disease: Insights From a Multinational Immunome Project Consortium for Autoinflammatory Disorders.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 29, 2025
Proteomic Biomarkers Are Linked to QTc Interval in Patients With Chronic Heart Failure.
Journal: Proteomics. Clinical applications
Published: July 28, 2025
Immunotherapy for rapid bone marrow conditioning and leukemia depletion that allows efficient hematopoietic stem cell transplantation.
Journal: Journal for immunotherapy of cancer
Published: June 16, 2025
Proteomic biomarkers and biological pathways associated with atrial fibrillation in heart failure patients with reduced ejection fraction.
Journal: Heart rhythm O2
Published: May 08, 2025
Microbial dysbiosis fuels STING-driven autoinflammation through cyclic dinucleotides.
Journal: Journal of autoimmunity
Published: February 14, 2025
Elevated serum levels of interleukin-18 discriminate Still's disease from other autoinflammatory conditions: results from the European ImmunAID cohort.
Journal: RMD open
Published: December 21, 2024
The immune response to SARS-CoV-2 in COVID-19 as a recall response susceptible to immune imprinting: A prospective cohort study.
Journal: Clinical immunology (Orlando, Fla.)
Published: November 20, 2024
A novel TOX-nanoluciferase reporter mouse for exploring modulators of T cell exhaustion.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 17, 2024
Last Updated: 09/26/2026